219 related articles for article (PubMed ID: 21833806)
21. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique.
Ricke J; Wust P; Stohlmann A; Beck A; Cho CH; Pech M; Wieners G; Spors B; Werk M; Rosner C; Hänninen EL; Felix R
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1496-505. PubMed ID: 15050329
[TBL] [Abstract][Full Text] [Related]
22. Treatment for liver metastasis from renal cell carcinoma with computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT): a case series.
Geisel D; Collettini F; Denecke T; Grieser C; Flörcken A; Wust P; Hamm B; Gebauer B
World J Urol; 2013 Dec; 31(6):1525-30. PubMed ID: 23132612
[TBL] [Abstract][Full Text] [Related]
23. Complications of Computed Tomography-Guided High-Dose-Rate Brachytherapy (CT-HDRBT) and Risk Factors: Results from More than 10 Years of Experience.
Böning G; Büttner L; Jonczyk M; Lüdemann WM; Denecke T; Schnapauff D; Wieners G; Wust P; Gebauer B
Cardiovasc Intervent Radiol; 2020 Feb; 43(2):284-294. PubMed ID: 31797103
[TBL] [Abstract][Full Text] [Related]
24. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
[TBL] [Abstract][Full Text] [Related]
25. Activity-based cost analysis of hepatic tumor ablation using CT-guided high-dose rate brachytherapy or CT-guided radiofrequency ablation in hepatocellular carcinoma.
Schnapauff D; Collettini F; Steffen I; Wieners G; Hamm B; Gebauer B; Maurer MH
Radiat Oncol; 2016 Feb; 11():26. PubMed ID: 26911437
[TBL] [Abstract][Full Text] [Related]
26. Image-guided Interstitial Brachytherapy in the Management of Metastasized Anal Squamous Cell Carcinoma.
Heinze C; Omari J; Othmer M; Hass P; Seidensticker M; Damm R; Ricke J; Pech M; Powerski MJ
Anticancer Res; 2018 Sep; 38(9):5401-5407. PubMed ID: 30194195
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound-assisted catheter placement in CT-guided HDR brachytherapy for the local ablation of abdominal malignancies: Initial experience.
Damm R; El-Sanosy S; Omari J; Damm R; Hass P; Pech M; Powerski M
Rofo; 2019 Jan; 191(1):48-53. PubMed ID: 30308690
[TBL] [Abstract][Full Text] [Related]
28. [Percutaneous treatment of hilar cholangiocarcinoma completed by high-dose rate brachytherapy. Experience in the first 5 cases].
Righi D; Maass J; Zanon E; Tettoni S; Orecchia R; Lazzari R; Ragona R; Gandini G
Radiol Med; 1994; 88(1-2):79-85. PubMed ID: 7520594
[TBL] [Abstract][Full Text] [Related]
29. Value of combined PET/CT for radiation planning in CT-guided percutaneous interstitial high-dose-rate single-fraction brachytherapy for colorectal liver metastases.
Steffen IG; Wust P; Rühl R; Grieser C; Schnapauff D; Lüdemann L; Grabik W; Ricke J; Amthauer H; Hamm B; Hänninen EL; Denecke T
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1178-85. PubMed ID: 20056343
[TBL] [Abstract][Full Text] [Related]
30. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
Mohnike K; Wieners G; Schwartz F; Seidensticker M; Pech M; Ruehl R; Wust P; Lopez-Hänninen E; Gademann G; Peters N; Berg T; Malfertheiner P; Ricke J
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):172-9. PubMed ID: 20056348
[TBL] [Abstract][Full Text] [Related]
31. Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma.
Kim JH; Won HJ; Shin YM; Kim KA; Kim PN
AJR Am J Roentgenol; 2011 Feb; 196(2):W205-9. PubMed ID: 21257864
[TBL] [Abstract][Full Text] [Related]
32. CT-guided high-dose-rate brachytherapy of metachronous ovarian cancer metastasis to the liver: initial experience.
Collettini F; Poellinger A; Schnapauff D; Denecke T; Wust P; Braicu IE; Sehouli J; Hamm B; Gebauer B
Anticancer Res; 2011 Aug; 31(8):2597-602. PubMed ID: 21778310
[TBL] [Abstract][Full Text] [Related]
33. In vivo assessment of the gastric mucosal tolerance dose after single fraction, small volume irradiation of liver malignancies by computed tomography-guided, high-dose-rate brachytherapy.
Streitparth F; Pech M; Böhmig M; Ruehl R; Peters N; Wieners G; Steinberg J; Lopez-Haenninen E; Felix R; Wust P; Ricke J
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1479-86. PubMed ID: 16757131
[TBL] [Abstract][Full Text] [Related]
34. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.
Dyk P; Jiang N; Sun B; DeWees TA; Fowler KJ; Narra V; Garcia-Ramirez JL; Schwarz JK; Grigsby PW
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):794-801. PubMed ID: 25245584
[TBL] [Abstract][Full Text] [Related]
35. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy.
Ricke J; Mohnike K; Pech M; Seidensticker M; Rühl R; Wieners G; Gaffke G; Kropf S; Felix R; Wust P
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):479-85. PubMed ID: 20304566
[TBL] [Abstract][Full Text] [Related]
36. Primary and metastatic malignancies of the lung: Retrospective analysis of the CT-guided high-dose rate brachytherapy (CT-HDRBT) ablation in tumours <4 cm and ≥4 cm.
Jonczyk M; Collettini F; Schnapauff D; Geisel D; Böning G; Feldhaus F; Wieners G; Hamm B; Gebauer B
Eur J Radiol; 2018 Nov; 108():230-235. PubMed ID: 30396661
[TBL] [Abstract][Full Text] [Related]
37. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
38. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution.
Burger I; Hong K; Schulick R; Georgiades C; Thuluvath P; Choti M; Kamel I; Geschwind JF
J Vasc Interv Radiol; 2005 Mar; 16(3):353-61. PubMed ID: 15758131
[TBL] [Abstract][Full Text] [Related]
39. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
Válek V; Kysela P; Kala Z; Kiss I; Tomásek J; Petera J
Eur J Radiol; 2007 May; 62(2):175-9. PubMed ID: 17344008
[TBL] [Abstract][Full Text] [Related]
40. Radiofrequency ablation for intrahepatic cholangiocarcinoma: retrospective analysis of a single centre experience.
Giorgio A; Calisti G; DE Stefano G; Farella N; DI Sarno A; Amendola F; Scognamiglio U; Giorgio V
Anticancer Res; 2011 Dec; 31(12):4575-80. PubMed ID: 22199333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]